Why do I have recurrent bile duct infections?

Recurrent bile duct infections (cholangitis) typically occur due to blockages from gallstones, strictures, or anatomical abnormalities that allow bacteria to multiply. Treatment involves antibiotics, addressing underlying causes, and sometimes surgical intervention to prevent future episodes.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Bile Duct Infections

Bile duct infections, medically known as cholangitis, occur when bacteria invade the biliary system that carries bile from your liver to your small intestine. While a single episode can be concerning enough, recurrent infections signal an underlying problem that needs attention. These repeated infections can lead to serious complications including liver damage, sepsis, and even life-threatening conditions if left untreated.

The bile ducts form a complex network of tubes that transport bile, a digestive fluid produced by your liver. When this system becomes compromised, bacteria from your intestines can travel upstream and multiply, causing inflammation and infection. Understanding why these infections keep returning is crucial for breaking the cycle and protecting your long-term health.

Common Causes of Recurrent Cholangitis

Gallstones and Biliary Obstruction

The most frequent culprit behind recurrent bile duct infections is gallstones. These hardened deposits can migrate from the gallbladder into the common bile duct, creating a blockage that prevents normal bile flow. When bile backs up, it creates an ideal environment for bacterial growth. Studies show that up to 70% of cholangitis cases are associated with choledocholithiasis (bile duct stones).

Risk Factors for Gallstone Formation

Understanding modifiable risk factors can help reduce gallstone formation and subsequent bile duct infections.
Risk FactorRelative Risk IncreaseMechanismModifiable
ObesityObesity (BMI >30)2-3xIncreased cholesterol secretion in bileYes
Rapid weight lossRapid weight loss1.5-2xBile supersaturation, decreased gallbladder motilityYes
Female genderFemale gender2xEstrogen effects on bile compositionNo
Age over 40Age over 404xDecreased bile acid synthesisNo
DiabetesDiabetes1.5xImpaired gallbladder motilityPartially

Understanding modifiable risk factors can help reduce gallstone formation and subsequent bile duct infections.

Even after successful stone removal, some patients continue experiencing infections due to residual debris, new stone formation, or damage to the bile duct from previous stones. Risk factors for gallstone formation include obesity, rapid weight loss, pregnancy, and certain medications.

Biliary Strictures

Strictures, or narrowing of the bile ducts, represent another major cause of recurrent infections. These can develop from various sources including chronic inflammation, previous surgeries, radiation therapy, or autoimmune conditions like primary sclerosing cholangitis (PSC). The narrowed passages slow bile flow, allowing bacteria to accumulate and multiply.

Post-surgical strictures are particularly common after liver transplantation or gallbladder removal, affecting up to 15% of patients. These strictures may not manifest immediately, sometimes developing months or years after the initial procedure, leading to unexpected recurrent infections.

Anatomical Abnormalities

Some individuals are born with or develop anatomical variations that predispose them to recurrent infections. Choledochal cysts, rare dilations of the bile ducts, can harbor bacteria and debris. Caroli disease, a congenital disorder causing intrahepatic bile duct dilation, significantly increases infection risk. Additionally, abnormal connections between the bile and pancreatic ducts can allow digestive enzymes to damage the biliary system.

Recognizing Symptoms and Warning Signs

Recurrent bile duct infections often follow a pattern of symptoms known as Charcot's triad: fever, jaundice (yellowing of skin and eyes), and right upper abdominal pain. However, not all patients experience all three symptoms. Some may have subtle signs like general malaise, loss of appetite, or mild discomfort that gradually worsens.

More severe cases can progress to Reynolds' pentad, which includes the original three symptoms plus confusion and hypotension (low blood pressure), indicating septic shock. This medical emergency requires immediate intervention. Between episodes, many patients feel completely normal, which can make it challenging to identify and address the underlying cause.

Diagnostic Approaches and Testing

Diagnosing recurrent bile duct infections requires a comprehensive approach combining blood tests, imaging studies, and sometimes invasive procedures. Blood work typically reveals elevated white blood cells, liver enzymes (particularly alkaline phosphatase and bilirubin), and inflammatory markers like C-reactive protein. Regular monitoring of these biomarkers can help track infection patterns and treatment response. If you're interested in understanding your liver health markers and inflammatory status between episodes, comprehensive testing can provide valuable baseline data.

Imaging Studies

Ultrasound often serves as the first-line imaging tool, capable of detecting dilated bile ducts and gallstones. However, it may miss smaller stones or subtle strictures. Magnetic resonance cholangiopancreatography (MRCP) provides detailed, non-invasive visualization of the entire biliary tree. For complex cases, endoscopic retrograde cholangiopancreatography (ERCP) combines diagnosis with potential treatment, allowing direct visualization and intervention.

Microbiological Testing

Bile cultures obtained during ERCP or percutaneous drainage help identify specific bacteria causing infections. Common culprits include E. coli, Klebsiella, and Enterococcus species. In recurrent cases, antibiotic resistance patterns become crucial for guiding treatment. Some patients may harbor unusual organisms or develop fungal infections, particularly if immunocompromised.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Treatment Strategies for Breaking the Cycle

Managing recurrent bile duct infections requires both treating acute episodes and addressing underlying causes. Initial treatment typically involves broad-spectrum antibiotics, fluid resuscitation, and pain management. However, antibiotics alone rarely solve the problem if structural issues persist.

Endoscopic Interventions

ERCP with sphincterotomy (cutting the sphincter muscle) can remove stones and improve drainage. For strictures, balloon dilation or stent placement may be necessary. Plastic stents require replacement every 3-4 months, while metal stents last longer but are more expensive. Some patients need multiple procedures to achieve adequate drainage.

Surgical Options

When endoscopic management fails or isn't feasible, surgery becomes necessary. Cholecystectomy (gallbladder removal) prevents future gallstone formation. For complex strictures or recurrent stones, hepaticojejunostomy or choledochojejunostomy creates an alternative drainage pathway. In severe cases with localized liver damage, partial hepatectomy may be required.

Prevention and Long-term Management

Preventing recurrent infections involves addressing modifiable risk factors and maintaining optimal biliary drainage. Weight management, dietary modifications, and treating underlying metabolic conditions can reduce gallstone formation. For patients with strictures or anatomical abnormalities, regular surveillance with imaging and liver function tests helps detect problems early.

Some patients benefit from prophylactic antibiotics, particularly those with permanent stents or immunosuppression. Ursodeoxycholic acid may help prevent stone formation and improve bile flow in certain conditions. Regular monitoring of inflammatory markers and liver enzymes can help identify subclinical infections before they become severe. For comprehensive tracking of your liver health and inflammatory status, consider regular biomarker testing to establish your baseline and monitor changes over time.

Lifestyle Modifications

  • Maintain a healthy weight through balanced diet and regular exercise
  • Limit high-fat foods that can trigger gallbladder contractions
  • Stay hydrated to maintain proper bile consistency
  • Avoid rapid weight loss, which can promote gallstone formation
  • Manage diabetes and metabolic syndrome to reduce infection risk
  • Consider probiotic supplementation to support gut health

When to Seek Immediate Medical Care

While managing recurrent infections often becomes routine for some patients, certain symptoms demand immediate medical attention. High fever above 101°F, severe abdominal pain, persistent vomiting, confusion, or signs of shock require emergency evaluation. Early intervention can prevent progression to sepsis and organ failure.

Patients with known bile duct issues should maintain open communication with their healthcare team and have an action plan for managing acute episodes. This might include having antibiotics on hand, knowing which emergency department to visit, and maintaining updated medical records accessible to emergency providers.

Living with Recurrent Bile Duct Infections

Managing recurrent bile duct infections requires patience, persistence, and partnership with your healthcare team. While the cycle of infections can feel overwhelming, most patients achieve good long-term outcomes with appropriate treatment. Understanding your specific risk factors, recognizing early warning signs, and maintaining preventive measures can significantly reduce infection frequency and severity.

For those interested in taking a proactive approach to their health monitoring, regular blood work can help track liver function and inflammatory markers between episodes. You can also upload your existing blood test results for a comprehensive analysis that helps you understand your biomarkers in the context of your bile duct health. This free service provides personalized insights and tracks changes over time, empowering you to work more effectively with your healthcare team.

Remember that recurrent infections don't have to define your life. With proper diagnosis, targeted treatment, and ongoing management, most people with bile duct issues can maintain good quality of life and prevent serious complications. Stay informed, stay vigilant, and don't hesitate to advocate for yourself when symptoms arise.

References

  1. Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):17-30.[Link][PubMed][DOI]
  2. Zimmer V, Lammert F. Acute Bacterial Cholangitis. Viszeralmedizin. 2015;31(3):166-172.[Link][PubMed][DOI]
  3. Ahmed M. Acute cholangitis - an update. World J Gastrointest Pathophysiol. 2018;9(1):1-7.[Link][PubMed][DOI]
  4. Sokal A, Sauvanet A, Fantin B, de Lastours V. Acute cholangitis: Diagnosis and management. J Visc Surg. 2019;156(6):515-525.[Link][PubMed][DOI]
  5. Tanaka A, Takikawa H. Primary sclerosing cholangitis and primary biliary cirrhosis. Dig Dis. 2015;33(2):158-164.[Link][PubMed][DOI]
  6. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230-239.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my liver function and inflammatory markers at home?

You can monitor your liver health and inflammation at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive liver enzyme testing (ALT, AST, ALP, bilirubin) and inflammatory markers like high-sensitivity CRP, providing lab-quality results from the comfort of your home.

What's the difference between acute and chronic cholangitis?

Acute cholangitis is a sudden bacterial infection of the bile ducts requiring immediate treatment, while chronic cholangitis involves repeated infections or persistent inflammation that can lead to permanent bile duct damage and cirrhosis over time.

Can bile duct infections be completely cured?

While individual infections can be treated with antibiotics, recurrent infections often require addressing underlying causes like gallstones or strictures. With proper treatment of these root causes, many patients can achieve long-term freedom from infections.

Are bile duct infections contagious?

No, bile duct infections are not contagious. They result from bacteria already present in your digestive system traveling into the bile ducts when normal drainage is impaired, not from person-to-person transmission.

What dietary changes can help prevent recurrent bile duct infections?

A low-fat, high-fiber diet can reduce gallstone risk. Avoid rapid weight loss, stay hydrated, limit refined sugars, and include foods rich in omega-3 fatty acids. Some patients benefit from smaller, more frequent meals rather than large portions.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details